Related Experiment Video
Updated: Aug 10, 2026

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
Brain corticotropin-releasing hormone- and interleukin-1 beta-induced suppression of specific antibody production
1Department of Psychiatry, University of California, San Diego.
Abstract:
CRH serves as a central nervous system mediator of autonomic and visceral responses to stress. In addition, central infusion of CRH has a role in the modulation of in vitro correlates of cell-mediated immune function, such as natural killer cell activity and T-lymphocyte proliferation. The present study examined the effects of central CRH on an integrated in vivo immune response, specific antibody production to a novel antigen. Synthetic rat CRH (1.0 micrograms) microinjected into the lateral ventricle significantly (P < 0.001) slowed the induction of a specific immunoglobulin G (IgG) antibody response to the T-cell-dependent antigen keyhole limpet hemocyanin (KLH) after either primary or secondary immunization. CRH-induced suppression of the IgG response in vivo was found after immunization with a low threshold dose of KLH, but not when a 100-fold increased dose of antigen was given. Administration of CRH 20 min before immunization reduced the antibody response, whereas CRH infusion 24 h after KLH exposure failed to alter antibody levels, suggesting that CRH alters initial antigen processing. These effects of CRH on an in vivo antibody response were due to the infusion of CRH into the brain, as a 1.0-micrograms dose of CRH injected either ip or sc had no effect. In addition, central coadministration of the CRH antagonist alpha-helical CRH-(9-41) significantly blocked the immunosuppressive action of CRH. Finally, as central interleukin-1 beta has been reported to modulate cellular immunity, we examined the effect of central infusion of interleukin-1 beta on the KLH antibody response and found that intracerebroventricular interleukin-1 beta (50 ng) produced a significant (P < 0.001) suppression of the IgG response to KLH. These findings extend previous data on central CRH-induced suppression of in vitro measures of cellular immunity and demonstrate that CRH acts in the brain to reduce an in vivo antibody response.
More Related Videos
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
06:37Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
Related Concept Videos
Humoral Immune Responses
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease III: Crohn's Disease